Axon officer plans sale of 16,775 shares via trust

Axon Enterprise, Inc. (AXON) is named as the issuer in a notice of proposed resale of common stock under Rule 144 filed for the account of officer Joshua Isner.

Rhea-AI Filing Summary

Axon Enterprise, Inc. (AXON) is named as the issuer in a notice of proposed resale of common stock under Rule 144 filed for the account of officer Joshua Isner. The filing covers a proposed sale of 16,775 shares of common stock through J.P. Morgan Securities LLC, with an aggregate market value of $10,077,245.75, when Axon had 81,237,415 shares outstanding as of 08/31/2026. The shares were acquired via RSU vesting on 08/13/2026 as compensation from the issuer.

The filing also reports that, during the prior three months, the Stool and Stars Revocable Trust, for which Joshua Isner serves as trustee, sold 34,000 shares of Axon common stock on 06/05/2026 for $16,589,351.40. The new shares covered by this notice are to be sold by that same trust.

Key Figures

Shares to be sold: 16,775 shares of common stock Aggregate market value: $10,077,245.75 Shares outstanding: 81,237,415 shares +3 more

6 metrics

Shares to be sold 16,775 shares of common stock Covered by the Rule 144 notice for Joshua Isner

Aggregate market value $10,077,245.75 Value of 16,775 Axon shares listed for proposed sale

Shares outstanding 81,237,415 shares Axon common shares outstanding as of 08/31/2026

Past 3-month sale shares 34,000 shares Sold by Stool and Stars Revocable Trust on 06/05/2026

Past 3-month sale value $16,589,351.40 Proceeds from 34,000 shares sold on 06/05/2026

RSU vesting acquisition date 08/13/2026 Date the 16,775 shares were acquired via RSU vesting

Key Terms

Rule 144, RSU Vesting, Revocable Trust, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

RSU Vesting financial

"Common Stock | 08/13/2026 | RSU Vesting | Issuer"

RSU vesting is the process by which restricted stock units — a promise by a company to give shares to an employee — become actual, owned shares over time or when certain goals are met. Investors care because vested shares can dilute existing ownership when issued, and the timing of vesting affects when employees can sell shares, which can influence share supply, insider selling patterns, and company incentives.

Revocable Trust financial

"Stool and Stars Revocable Trust Care of Axon Enterprise, Inc."

A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.

attorney-in-fact regulatory

"as agent and attorney-in-fact for Joshua Isner"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What volume of Axon (AXON) shares is covered by Joshua Isner’s Rule 144 notice?

The notice covers a proposed sale of 16,775 shares of Axon Enterprise, Inc. common stock. These shares are to be sold under Rule 144 through J.P. Morgan Securities LLC and were originally acquired via RSU vesting on 08/13/2026 as compensation.

What is the aggregate market value of the Axon (AXON) shares in this Form 144 filing?

The filing lists an aggregate market value of $10,077,245.75 for the 16,775 Axon common shares covered by the notice, as associated with the proposed Rule 144 sale through J.P. Morgan Securities LLC.

How many Axon (AXON) shares were outstanding when this Rule 144 sale was noted?

The filing reports that Axon Enterprise, Inc. had 81,237,415 shares outstanding as of 08/31/2026. This figure provides context for the size of the proposed 16,775-share sale under Rule 144.

What prior Axon (AXON) share sales are disclosed for the past three months?

The document states that the Stool and Stars Revocable Trust sold 34,000 shares of Axon common stock on 06/05/2026 for $16,589,351.40. This transaction is disclosed as part of the three-month sales history.

Who is actually selling the Axon (AXON) shares in this Rule 144 filing?

The shares are to be sold by the Stool and Stars Revocable Trust, with Joshua Isner acting as trustee. The filing explains that Mr. Isner originally acquired the shares as RSU awards on 08/13/2026 before they were held by the trust.

What is the relationship between the Axon (AXON) shares and RSU vesting in this filing?

The filing explains that the 16,775 shares subject to the Rule 144 notice were originally acquired by Joshua Isner as RSU awards that vested on 08/13/2026 and are characterized as compensation from Axon Enterprise, Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/31/2026 - 06:20 PM EDT Accepted by SEC EDGAR 08/31/2026 - 06:19 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001648518
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Axon Enterprise, Inc.
SEC File Number	001-16391
Address of Issuer	17800 North 85th Street Scottsdale ARIZONA 85255
Phone	480-991-0797
Name of Person for Whose Account the Securities are To Be Sold	Joshua Isner
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 270 Park Avenue, 10th Floor New York NY 10017	16775	10077245.75	81237415	08/31/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/13/2026	RSU Vesting	Issuer			16775	08/13/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Stool and Stars Revocable Trust Care of Axon Enterprise, Inc. 17800 North 85th Street Scottsdale AZ 85255	Common	06/05/2026	34000	16589351.4

144: Remarks and Signature

Remarks	The shares covered by this filing will be sold by the Stool and Stars Revocable Trust, Joshua Isner as Trustee. Mr. Isner originally acquired the shares as RSU awards on 8/13/2026.
Date of Notice	08/31/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/01/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Joshua Isner
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)